Sponsor
Verve Therapeutics Inc.
201 Brookline Avenue Suite 601, 02215-4153, United States
About the sponsor
Research activity is centered on refractory hyperlipidemia, with clinical interest in patients whose cholesterol levels remain difficult to control through standard treatment approaches.
- Refractory hyperlipidemia
- Severe dyslipidemia
- Lipid metabolism
The therapeutic focus reflects involvement in cardiovascular risk reduction and the management of persistent abnormalities in blood lipid levels.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.